Russell Bradley Named President & General Manager of CNSideDr. Marc Hedrick, Rick Hawkins, and Russell Bradley Join CNSide Board of ...

Some New York doctors are working on new ways to treat advanced cancers. Chimeric Antigen Receptor, or CAR, T-cell therapy ...

The firm will test additional doses and use its proprietary drug response predictor to gather data that can inform a registrational study.

Some New York doctors are working on new ways to treat advanced cancers. Chimeric Antigen Receptor, or CAR, T-cell therapy ...

A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...

Navigating Therapies for BCG-Unresponsive NMIBC: Immunotherapies and Chemotherapies Experts discuss the evolving landscape of chemotherapy and immunotherapy options for patients with non-muscle ...

These drugs, discovered decades ago, continue to save lives today, but more recent research has led to the development of ...

Eligibility issues, a need for better multidisciplinary collaboration, and a lack of incorporation in community practices are ...

And there have been advances that have helped all Americans. And we would never have had the COVID-19 vaccines without NIH ...

Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...